Simona B.
- Country
- Slovenia
- Department
- Sektor internistične onkologije
Research Overview
- A Phase II Study of Cell-Based Immunotherapy for the Treatment of Stage II and III Triple-Negative Breast Cancer
- Efficacy and Safety of Giredestrant vs. Fulvestrant with CDK4/6 Inhibitor in ER+ HER2- Advanced Breast Cancer Resistant to Endocrine Therapy
- Evaluation of Cell-Based Immunotherapy in Patients with Stage II and III Triple Negative Breast Cancer
Data & Insights
Has run more than one trial at 1 of 106 partner sites.
Specializations
Breast Cancer Specialization
This investigator demonstrates focused expertise in treating various forms of breast cancer, with particular emphasis on hormone receptor-positive variants.
- ER-positive HER2-negative breast cancer
- Triple negative breast cancer
- Advanced breast cancer
The investigator's work encompasses both early-stage and advanced disease states.
Therapeutic Approaches
The investigator explores multiple treatment modalities for breast cancer management.
- Endocrine therapy
- Cell-based immunotherapy
- Targeted molecular treatments
Their work includes evaluation of novel therapeutic agents against established treatment standards.
Treatment Innovation
The investigator's research focuses on advancing therapeutic options for specific breast cancer subtypes.
- Hormone-resistant disease management
- Adjuvant therapy optimization
- Novel therapeutic development
Their work addresses both treatment-resistant cases and early intervention strategies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.